Premixed human insulin (thrice-daily)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Premixed human insulin (thrice-daily), covering 2025-03-04 to 2025-03-04. Get the full timeline:
Most recent: Clinical Trial Update: Comparison of Thrice-Daily Premixed Human Insulin With Basal-Bolus Therapy Among Patients With Poorly Controlled Type 2 Diabetes Mellitus [Phase 4]